May 2026
1. SHEN N, Ramanathan S, Horns JJ, Hyngstrom JR, et al
   Corrigendum to "The benefit of sentinel lymph node biopsy in elderly patients with melanoma: A retrospective analysis of SEER-Medicare data (2010-2018)" [Am J Surg 237 (2024) 115896].
   Am J Surg. 2026 May 21:117041. doi: 10.1016/j.amjsurg.2026.117041.
   

   >> Share

   
   February 2026
2. MONTGOMERY KB, Rademacher N, Richman JS, Bhatia S, et al
   Healthcare facility volume and evidence-based practice implementation in surgical care of patients with common cancers.
   Am J Surg. 2026;252:116733.
   

   >> Share

   
   November 2025
3. KELLER HR, Hanes DA, Lascano D, McCabe JK, et al
   Male or female sex stratified by age does not impact survival in patients with metastatic melanoma receiving immunotherapy.
   Am J Surg. 2025;251:116710.
   

   >> Share

   
   October 2025
4. SOFIELD HE, Buchner SH, Nation RJ, Hess TN, et al
   Treatment patterns of anal melanoma in the era of immunotherapy.
   Am J Surg. 2025;250:116658.
   

   >> Share

   
   May 2025
5. GUNDER MA, Stephens KR, Donica W, McMasters KM, et al
   Predicting who may benefit from adjuvant immunotherapy in stage IIB melanoma.
   Am J Surg. 2025;247:116450.
   

   >> Share

   
   February 2025
6. MORRISON SL, Han G, Elenwa F, Leong SP, et al
   Tumor infiltrating lymphocytes in primary melanoma are associated with a better prognosis.
   Am J Surg. 2025 Feb 8:116243. doi: 10.1016/j.amjsurg.2025.116243.
   

   >> Share

   
   January 2025
7. WILSON NR, Angeles CV, Haykal T
   Neoadjuvant treatment in advanced resectable melanoma and the need for a predictive biomarker - is pathologic complete response (pCR) the answer?
   Am J Surg. 2025 Jan 21:116207. doi: 10.1016/j.amjsurg.2025.116207.
   

   >> Share

   
   December 2024
8. MCCAHILL LE
   Changes in the surgical management of melanoma and measures to implement change.
   Am J Surg. 2024;241:116129.
   

   >> Share

   
   October 2024
9. JIMINEZ V, Montgomery KB, Hollenquest B, Broman KK, et al
   Long-term outcomes of nodal surveillance practices in sentinel node positive melanoma: An early post MSLT-II cohort.
   Am J Surg. 2024;239:116049.
   

   >> Share

   
   August 2024
10. SHEN N, Ramanathan S, Horns JJ, Hyngstrom JR, et al
    The benefit of sentinel lymph node biopsy in elderly patients with melanoma: A retrospective analysis of SEER Medicare data (2010-2018).
    Am J Surg. 2024;237:115896.
    

    >> Share

    
    June 2024
11. HAYKAL T, Contreras C
    Adjuvant PD-1-based therapies for high-risk resected melanomas are here to stay.
    Am J Surg. 2024 Jun 1:115791. doi: 10.1016/j.amjsurg.2024.115791.
    

    >> Share

    
    February 2024
12. VALENZUELA CD, Fowler G, Kozuma K, Kusaka S, et al
    Long-term outcomes after amputation and sentinel node biopsy for subungual melanoma: A single-institution series.
    Am J Surg. 2024 Feb 24:S0002-9610(24)00138-7. doi: 10.1016/j.amjsurg.2024.
    

    >> Share

    
    
13. DOWNEY J, Hamm J, Baliski C
    Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
    Am J Surg. 2024 Feb 2:S0002-9610(24)00029-1. doi: 10.1016/j.amjsurg.2024.
    

    >> Share

    
    October 2023
14. WILSON AK, Lourdault K, Ostad T, Stern S, et al
    Is therapeutic lymph node dissection of value for lymph node recurrence in melanoma?
    Am J Surg. 2023 Oct 17:S0002-9610(23)00564-0. doi: 10.1016/j.amjsurg.2023.
    

    >> Share

    
    September 2023
15. HANUSCHAK D, DePiero M, DeMoraes M, Bailly S, et al
    The impact of COVID-19 on patients diagnosed with melanoma, breast, and colorectal cancer.
    Am J Surg. 2023 Sep 29:S0002-9610(23)00496-8. doi: 10.1016/j.amjsurg.2023.
    

    >> Share

    
    
16. ISTL AC
    Skin in the Game: Surgical delays in our patients with melanoma.
    Am J Surg. 2023 Sep 15:S0002-9610(23)00473-7. doi: 10.1016/j.amjsurg.2023.
    

    >> Share

    
    May 2023
17. SCHWANTES IR, Sutton T, Behrens S, Fowler G, et al
    Metastasectomy for metastatic melanoma in the era of effective systemic therapy.
    Am J Surg. 2023 May 23:S0002-9610(23)00184-8. doi: 10.1016/j.amjsurg.2023.
    

    >> Share

    
    April 2023
18. HEWITT DB, Beane JD, Grignol VP, Contreras CM, et al
    Association between surgical delay and outcomes among patients with invasive cutaneous melanoma.
    Am J Surg. 2023 Apr 29:S0002-9610(23)00183-6. doi: 10.1016/j.amjsurg.2023.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share